KIDS — Orthopediatrics Income Statement
0.000.00%
- $685.32m
- $647.88m
- $148.73m
- 53
- 39
- 44
- 42
Annual income statement for Orthopediatrics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 72.6 | 71.1 | 98 | 122 | 149 |
Cost of Revenue | |||||
Gross Profit | 54.6 | 55 | 73.4 | 90.7 | 111 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 81.6 | 97.8 | 116 | 148 | 175 |
Operating Profit | -9.08 | -26.8 | -18 | -25.4 | -26.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.7 | -33.7 | -17.4 | -3.69 | -21.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.7 | -32.9 | -16.3 | 1.26 | -21 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -13.7 | -32.9 | -16.3 | 1.26 | -21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.7 | -32.9 | -16.3 | 1.26 | -21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.817 | -1.56 | -0.828 | 0.184 | -0.897 |